FDA Adverse Event Injury Summary report: N

NA

MDR report key: 22859975 · Received August 21, 2025

Report

Report Number
22859975
Event Type
Injury
Date Received
August 21, 2025
Date of Event
August 9, 2025
Report Date
August 15, 2025
Manufacturer
FOOTPRINT MEDICAL, INC.
Product Code
LJS
UDI-DI
00858778006072
Adverse Event
Yes
Report Source
User Facility report
Reporter Location
NY
Reporter Occupation
003

Narratives

Description of Event or Problem · 0

SINCE [DATE REDACTED] - LESS THAN ONE MONTH, HAVE BEEN 3 INDWELLING PICC [PERIPHERALLY INSERTED CENTRAL CATHETER] REQUIRING REMOVAL DUE TO OCCLUSION. THEY HAVE ALL BEEN THE SAME BRAND AND LOT#, 1.4FR PICC(S) FROM THE FOOTPRINT BRAND, LOT# 250098. PATIENT 1: PICC PLACED [DATE REDACTED]. REMOVED: THREE DAYS LATER [DATE REDACTED] - UNABLE TO FLUSH/OCCLUDED PATIENT WAS RECEIVING BOTH TPN AND AMPICILLIN. TPN PAUSED AND LINE CLAMPED WHILE AMPICILLIN WAS GIVEN. PATIENT 2: PICC PLACED [DATE REDACTED]. REMOVED THE FOLLOWING DAY [DATE REDACTED] - UNABLE TO FLUSH/OCCLUDED PATIENT WAS RECEIVING BOTH TPN AND AMPICILLIN. TPN PAUSED AND LINE CLAMPED WHILE AMPICILLIN WAS GIVEN. ADDITIONAL PICC PLACED [DATE REDACTED], REMOVED (PULLED OUT) ON [DATE REDACTED] - APPROXIMATELY 30 DAYS LATER. AT THIS TIME THE CLOT WAS NOTED. PATIENT WAS TREATED FOR LEFT CEPHALIC SUPERFICIAL VENOUS THROMBUS. ADDITIONAL PICC PLACED [DATE REDACTED], LOVENOX (ENOXAPARIN) GIVEN TO TREAT THROMBOSIS. PICC WAS REMOVED ON [DATE REDACTED] - 10 DAYS LATER, WITH NO ISSUES WITH THE LINE. PATIENT 3: PICC PLACED [DATE REDACTED]. REMOVED [DATE REDACTED] - APPROXIMATELY 7 DAYS LATER - UNABLE TO FLUSH/OCCLUDED PATIENT WAS RECEIVING BOTH TPN AND AMPICILLIN. TPN PAUSED AND LINE CLAMPED WHILE AMPICILLIN WAS GIVEN. OCCLUSION OF PICC LINE WAS NOT IMMEDIATELY FOLLOWING AMPICILLIN INFUSION, BUT OCCURRED WITHIN 24 HOURS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2204549 NA CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS LJS FOOTPRINT MEDICAL, INC. P1PIC1.4-S 250098 00858778006072

Patients

Seq Age Sex Outcome Treatment
1 10 DA Male Required Intervention